Mutagenic action of 5-nitroimidazoles: In vivo induction of GC → CG transversion in two Bacteroides fragilis reporter genes

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 398, Issue 1-2, 1998, Pages 55-65

  Trinh, Stéphanie ^a   Reysset, Gilles ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

5 Nitroimidazole; Bacteroides fragilis; Dimetridazole; Metronidazole; Mutation; NimA Gene; TerQ Gene; Transversion

Indexed keywords

5 NITROIMIDAZOLE DERIVATIVE; DIMETRIDAZOLE; METRONIDAZOLE;

ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEROIDES FRAGILIS; CONTROLLED STUDY; DNA STRAND; DRUG CARCINOGENICITY; GENE MUTATION; MOLECULE; MUTAGENESIS; MUTAGENIC ACTIVITY; MUTAGENICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REDUCTION; REPORTER GENE; REVERTANT;

AMINO ACID SEQUENCE; BACTEROIDES FRAGILIS; BASE SEQUENCE; DNA, BACTERIAL; GENES, REPORTER; MOLECULAR SEQUENCE DATA; MUTAGENS; MUTATION; NITROIMIDAZOLES; PLASMIDS; TETRACYCLINE RESISTANCE;

BACTERIA (MICROORGANISMS); BACTEROIDES FRAGILIS; NEGIBACTERIA;

EID: 0032574344     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00240-6     Document Type: Article

References (30)

1. S.M. Finegold, Anaerobic Bacteria in Human Disease, Academic Press, New York, 1977.
2. Edwards D.I. Nitroimidazole drugs - action and resistance mechanisms. I. Mechanisms of action J. Antimicrob. Chemother. 31:1993;9-20.
3. Müller M. Reductive activation of nitroimidazoles in anaerobic microorganisms. Biochem. Pharmacol. 35:1986;37-41.
4. Perez-Reyes E., Kalyanaraman B., Mason R.P. The reductive metabolism of metronidazole and ronidazole by aerobic liver microsomes. Mol. Pharmacol. 17:1979;239-244.
5. D.I. Edwards, R.J. Knox, D.A. Rowley, I.M. Skolimowski, R.C. Knight, The biochemistry of nitroimidazole drug action, in: H. Van den Bossche (Ed.), The Host-Invader, Elsevier, Amsterdam, 1980, pp. 673-676.
6. Knight R.C., Skolimowski I.M., Edwards D.I. The interaction of reduced metronidazole with DNA. Clin. Pharmacol. 27:1978;2089-2093.
7. Cantelli-Forti G., Aicardi G., Guerra M.C., Barbaro A.M., Biagi G.L. Mutagenicity of a series of 25 nitroimidazoles and two nitrothiazoles in Salmonella typhimurium. Teratogen. Carcinogen. Mutagen. 3:1983;51-63.
8. Chin J.B., Sheinin D.M.K., Rauth A.M. Screening for the mutagenicity of nitro-group containing hypoxic cell radiosensitizers using Salmonella typhimurium strains TA100 and TA98. Mutation Res. 58:1978;1-10.
9. H.S. Rozenkranz, W.T. Speck, Studies on the significance of the mutagenicity of metronidazole in Salmonella typhimurium, in: S.M. Finegold (Ed.), Metronidazole - Proceedings of the International Metronidazole Conference, Montreal, Quebec, Canada, Excerpta Medica, Amsterdam, 1977, pp. 119-125.
10. Mamber S.W., Okasinski W.G., Pinter C.D., Tunac J.B. The Escherichia coli K-12 SOS chromotest agar spot test for simple, rapid detection of genotoxic agents. Mutation Res. 171:1986;83-90.
11. Reysset G. Genetics of 5-nitroimidazole resistance in Bacteroides species. Anaerobe. 2:1996;59-69.
12. Privitera G., Dublanchet A., Sebald M. Transfer of multiple antibiotic resistance between subspecies of Bacteroides fragilis. J. Infect. Dis. 139:1979;97-101.
13. Reysset G., Haggoud A., Su W.J., Sebald M. Genetic and molecular analysis of pIP417 and pIP419: Bacteroides plasmids encoding 5-nitroimidazole resistance. Plasmid. 27:1992;181-190.
14. Haggoud A., Trinh S., Moumni M., Reysset G. Genetic analysis of the minimal replicon of plasmid pIP417 and comparison with the other encoding 5-nitroimidazole resistance plasmid from Bacteroides spp. Plasmid. 34:1995;132-143.
15. Birnboim H.C., Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1979;1513-1523.
16. Trinh S., Reysset G. Detection by PCR of the nim genes encoding 5-nitroimidazole resistance in Bacteroides spp. J. Clin. Microbiol. 34:1996;2078-2084.
17. J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning: a Laboratory Manual (2nd ed)., Cold Spring Harbor Laboratory Cold Spring Harbor, New York, 1989.
18. Nikolich M.P., Shoemaker N.B., Salyers A.A. A Bacteroides tetracycline resistance gene represents a new class of ribosome protection tetracycline resistance. Antimicrob. Agents Chemother. 36:1992;1005-1012.
19. Lépine G., Lacroix J.-M., Walker C.B., Progulske-Fox A. Sequencing of a tet (Q) gene isolated from Bacteroides fragilis 1126. Antimicrob. Agents Chemother. 37:1993;2037-2041.
20. Van Tassel R.L., Wilkins T.D. Isolation of auxotrophs of Bacteroides fragilis. Can. J. Microbiol. 24:1978;1619-1621.
21. Dobias L., Cerna M., Rössner P., Sram R. Genotoxicity and carcinogenicity of metronidazole. Mutation Res. 317:1994;177-194.
22. Plant C.W., Edwards D.I. The effect of tinidazole, metronidazole and nitrofurazone on nucleic acid synthesis in Clostridium bifermentans. J. Antimicrob. Chemother. 2:1976;203-209.
23. Tocher J.H., Edwards D.I. Evidence for the direct interaction of reduced metronidazole derivatives with DNA bases. Biochem. Pharmacol. 48:1994;1089-1094.
24. Church D.L., Bryant R.D., Rabin H.R., Laishley E.J. Physiological effects of metronidazole on the growth of Clostridium pasteurianum. J. Antimicrob. Chemother. 28:1991;221-228.
25. Rowley D.A., Knight R.C., Skolimowski I.M., Edwards D.I. The relationship between misonidazole cytotoxicity and base composition of DNA. Biochem. Pharmacol. 29:1980;2095-2098.
26. LaRusso N.F., Tomasz M., Müller M., Lipmann R. Interaction of metronidazole with nucleic acids in vitro. Mol. Pharmacol. 13:1977;872-882.
27. Declerck P.J., DeRanter C.J., Volkaert G. Base specific interaction of reductively activated nitroimidazoles with DNA. FEBS Lett. 164:1983;145-148.
28. Declerck P.J., DeRanter C.J. In vitro reductive activation of nitroimidazoles. Biochem. Pharmacol. 35:1986;59-61.
29. Knox R.J., Knight R.C., Edwards D.I. Misonidazole-induced thymine release from DNA. Biochem. Pharmacol. 30:1981;1925-1929.
30. Ralph E.D., Kirby W.M.M. Bioassay of metronidazole with either anaerobic or aerobic incubation. J. Infect. Dis. 132:1975;587-591.